CTO, Debulking Devices Poised To Profit From Ancillary Stenting Needs
This article was originally published in The Gray Sheet
Executive Summary
Lumend is developing a second-generation X-35 version of its Frontrunner chronic total occlusion catheter in anticipation of increasingly complex drug-eluting stent procedures